Download PDF
Thromb Haemost 1997; 78(01): 672-677
DOI: 10.1055/s-0038-1657610
Angiogenesis
Schattauer GmbH Stuttgart

Angiogenesis: a Dynamic Balance of Stimulators and Inhibitors

Luisa M Iruela-Arispe
Departments of Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA
,
Harold F Dvorak
Departments of Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA
› Author Affiliations
Further Information

Publication History

Publication Date:
12 July 2018 (online)

Also available at
  PDF Download  Permissions and Reprints
 

  • References

  • 1 Thomas KA, Gimenez-Gallego G. Fibroblast growth factors: broad spectrum mitogens with potent angiogenic activity. Trends Biochem Sci 1986; 11: 81-84
    CrossrefPubMedSearch in Google Scholar
  • 2 Schweigerer L, Neufeld G, Friedman J, Abraham JA, Fiddes JC, Gospodarowicz D. Capillary endothelial cells express basic fibroblast growth factor, a mitogen that promotes their own growth. Nature 1987; 325: 257-259
    CrossrefPubMedSearch in Google Scholar
  • 3 Yang EY, Moses HL. Transforming growth factor beta 1-induced changes in cell migration, proliferation, and angiogenesis in the chicken chorioallantoic membrane. J Cell Biol 1990; 111: 731-741
    CrossrefPubMedSearch in Google Scholar
  • 4 Folkman J, Klagsbrun M. Angiogenic factors. Science 1987; 235: 442-443
    CrossrefPubMedSearch in Google Scholar
  • 5 Ferrara N, Henzel WJ. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun 1989; 161: 851-858
    CrossrefPubMedSearch in Google Scholar
  • 6 Ferrara N, Carver-Moore K, Chen H, Dowd M, Lu L, O’Shea KS, Powell-Braxton L, Hillan KJ, Moore MW. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 1996; 380: 43942
    PubMedSearch in Google Scholar
  • 7 Carmeliet P, Verreira V, Breier G, Pollefeyt S, Kieckens L, Gertsenstein M, Fahrig M, Vandenhoeck A, Harpal K, Eberhardt C, Declercq C, Pawling J, Moons L, Collen D, Risau W, Nagy A. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 1996; 380: 435-439
    CrossrefPubMedSearch in Google Scholar
  • 8 Dvorak HF, Dvorak AM, Manseau EJ, Wiberg L, Churchill WH. Fibrin gel investment associated with line 1 and line 10 solid tumor growth, angiogenesis, and fibroplasia in guinea pigs. Role of cellular immunity, myofibroblasts, microvascular damage, and infarction in line 1 tumor regression. J Natl Cancer Inst 1979; 62: 1459-1472
    PubMedSearch in Google Scholar
  • 9 Dvorak HF, Brown LF, Detmar M, Dvorak AM. Vascular permeability factor/vascular endothelial growth factor, micro-vascular hyperpermeability, and angiogenesis. Am J Pathol 1995; 146: 1029-1039
    PubMedSearch in Google Scholar
  • 10 Brown L, Detmar M, Claffey K, Nagy J, Feng D, Dvorak A, Dvorak H. Vascular permeability factor/vascular endothelial growth factor: a multifunctional angiogenic cytokine. In: Control of Angiogenesis. Goldberg I, Rosen E. eds. Birkhauser Verlag, Basel; Switzerland: 1996. pp 233-269
    Search in Google Scholar
  • 11 Senger D, Van De WaterL, Brown L, Nagy J, Yeo K-T, Yeo T-K, Berse B, Jackman R, Dvorak A, Dvorak H. Vascular permeability factor (VPF, VEGF) in tumor biology. Cancer Metastasis Rev 1993; 12: 303-324
    CrossrefPubMedSearch in Google Scholar
  • 12 Dvorak HF, Harvey VS, Estrella P, Brown LF, McDonagh J, Dvorak AM. Fibrin containing gels induce angiogenesis. Implications for tumor stroma generation and wound healing. Lab Invest 1987; 57: 673-686
    PubMedSearch in Google Scholar
  • 13 Kohn S, Nagy JA, Dvorak HF, Dvorak AM. Pathways of macromolecular tracer transport across venules and small veins. Structural basis for the hyperpermeability of tumor blood vessels. Lab Invest 1992; 67: 596-607
    PubMedSearch in Google Scholar
  • 14 Feng D, Nagy J, Hipp J, Dvorak H, Dvorak A. Vesiculo-vacuolar organelles and the regulation of venule permeability to macromolecules by vascular permeability factor, histamine and serotonin. J Exp Med 1996; 183: 1981-1986
    CrossrefPubMedSearch in Google Scholar
  • 15 Park J, Keller G-A, Ferrara N. The vascular endothelial growth factor (VEGF) isoforms: differential deposition into the sub-epithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF. Mol Biol Cell 1993; 4: 1317-1326
    CrossrefPubMedSearch in Google Scholar
  • 16 Senger DR, Perruzzi CA, Feder J, Dvorak HF. A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines. Cancer Res 1986; 46: 5629-5632
    PubMedSearch in Google Scholar
  • 17 Maglione D, Guerriero V, Viglietto G, Delli-Bovi P, Persico MG. Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor. Proc Natl Acad Sci USA 1991; 88: 9267-9271
    CrossrefPubMedSearch in Google Scholar
  • 18 Joukov V, Pajusola K, Kaipainen A, Chilov D, Lahtinen I, Kukk E, Sakseia O, Kalkkinen N, Alitalo K. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the flt-4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBOJ 1996; 15: 290-298
    PubMedSearch in Google Scholar
  • 19 Dumont DJ, Yamaguchi TP, Conlon RA, Rossant J, Breitman ML. Tek, a novel tyrosine kinase gene located on mouse chromosome 4, is expressed in endothelial cells and their presumptive precursors. Oncogene 1992; 07: 1471-1480
    PubMedSearch in Google Scholar
  • 20 Sato TN, Qin Y, Kozak CA, Audus KL. Tie-1 and Tie-2 define another class of putative receptor tyrosine kinase genes expressed in early embryonic vascular system. Proc Natl Acad Sci USA 1993; 90: 9355-9358
    CrossrefPubMedSearch in Google Scholar
  • 21 Iwama A, Hamaguchi I, Hashiyama M, Murayama Y, Yasunaga K, Suda T. Molecular cloning and characterization of mouse Tie and Tek receptor tyrosine kinase genes and their expression in hematopoietic stem cells. Biochem Biophys Res Commun 1993; 195: 301-309
    CrossrefPubMedSearch in Google Scholar
  • 22 Mustonen T, Alitalo K. Endothelial receptor tyrosine kinases involved in angiogenesis. J Cell Biol 1995; 129: 895-898
    CrossrefPubMedSearch in Google Scholar
  • 23 Sato TN, Tozawa Y, Deutsch U, Wolburg-Bucholz K, Fujiwara Y, Gendron-Maguire M, Gridley T, Wolburg H, Risau W, Qin Y. Distinct roles of the receptor tyrosine kinase Tie-1 and Tie-2 in blood vessel formation. Nature 1995; 376: 70-74
    CrossrefPubMedSearch in Google Scholar
  • 24 Puri MC, Rossant J, Alitalo K, Bernstein A, Partanen J. The receptor tyrosine kinase Tie is required for integrity and survival of vascular endothelial cells. EMBOJ 1995; 14: 5884-5891
    PubMedSearch in Google Scholar
  • 25 Davis S, Aldrich TH, Jones PF, Acheson A, Compton DL, Jain V, Ryan TE, Bruno J, Radziejewski C, Maisonpierre PC, Yancopoulos GD. Isolation of angiopoetin-1, a ligand for the Tie-2 receptor, by secretion-trap expression cloning. Cell 1996; 87: 1161-1169
    CrossrefPubMedSearch in Google Scholar
  • 26 Suri C, Jones P, Patan S, Bartunkova S, Maisonpierre PC, Davies S, Sato TN, Yancopoulos GD. Requisite role of angiopoetin-1, a ligand for the Tie-2 receptor, during embryonic angiogenesis. Cell 1996; 87: 1171-1180
    CrossrefPubMedSearch in Google Scholar
  • 27 Langer R, Brem H, Falterman K, Klein M, Folkman J. Isolation of a cartilage factor that inhibits tumor neovascularization. Science 1976; 193: 70-72
    CrossrefPubMedSearch in Google Scholar
  • 28 Langer RS, Conn H, Vacanti J, Haudenschild C, Folkman J. Control of tumor growth in animals by infusion of an angiogenesis inhibitor. Proc Natl Acad Sci USA 1980; 77: 4431-4435
    PubMedSearch in Google Scholar
  • 29 Takigawa M, Shirai E, Enomoto M, Pan HO, Suzuki F, Shiio T, Yugari Y. A factor in conditioned medium of rabbit costal chondrocytes inhibits the proliferation of cultured endothelial cells and angiogenesis induced by B16 melanoma: its relation with cartilage-derived anti-tumor factor (CATF). Biochem Int 1985; 14: 357-363
    PubMedSearch in Google Scholar
  • 30 Peterson HI. Tumor angiogenesis inhibition by prostaglandin synthetase inhibitors. Anticancer Res 1986; 6: 251-254
    PubMedSearch in Google Scholar
  • 31 Taylor S, Folkman J. Protamine is an inhibitor of angiogenesis. Nature 1982; 297: 307-312
    CrossrefPubMedSearch in Google Scholar
  • 32 Ingber D, Fujita T, Kishimoto S, Sudo K, Kanamaru T, Brem H, Folkman J. Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumor growth. Nature 1990; 348: 555-558
    CrossrefPubMedSearch in Google Scholar
  • 33 O’Reilly MS, Holmgren L, Shing Y, Chen C, Rosenthal RA, Moses M, Lane WS, Cao Y, Sage EH, Folkman J. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 1994; 79: 315-328
    CrossrefPubMedSearch in Google Scholar
  • 34 O’Reilly MS, Boehm T, Shing Y, Fukai N, Vasios G, Lane WS, Flynn E, Birkhead JR, Olsen BR, Folkman J. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 1997; 88: 277-285
    CrossrefPubMedSearch in Google Scholar
  • 35 Fidler TJ, Ellis LM. The implications of angiogenesis for the biology and therapy of cancer metastasis. Cell 1994; 79: 185-188
    CrossrefPubMedSearch in Google Scholar
  • 36 Good DJ, Polverini PJ, Rastinejad F, Le Beau MM, Lemons RS, Frazier WA, Bouck NP. A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin. Proc Natl Acad Sci USA 1990; 87: 6624-6628
    CrossrefPubMedSearch in Google Scholar
  • 37 Rastinejad F, Polverini PJ, Bouck NP. Regulation of the activity of a new inhibitor of angiogenesis by a cancer suppressor gene. Cell 1989; 56: 345-355
    CrossrefPubMedSearch in Google Scholar
  • 38 Iruela-Arispe ML, Bornstein P, Sage H. Thrombospondin exerts an antiangiogenic effect on tube formation by endothelial cells in vitro. Proc Natl Acad Sci USA 1991; 88: 5026-5030
    CrossrefPubMedSearch in Google Scholar
  • 39 Iruela-Arispe ML, Porter P, Bornstein P, Sage EH. Thrombospondin-1, an inhibitor of angiogenesis, is regulated by progesterone in human stromal cells. J Clin Invest 1996; 97: 403-412
    CrossrefPubMedSearch in Google Scholar
  • 40 Mosher DF. Physiology of thrombospondin. Annu Rev Med 1990; 41: 85-97
    CrossrefPubMedSearch in Google Scholar
  • 41 Frazier WA. Thrombospondins. Curr Opin Cell Biol 1991; 3: 792-799
    CrossrefPubMedSearch in Google Scholar
  • 42 Majack RA, Cook SC, Bornstein P. Control of smooth muscle cell gowth by components of the extracellular matrix: autocrine role for thrombospondin. Proc Natl Acad Sci USA 1986; 83: 9050-9054
    CrossrefPubMedSearch in Google Scholar
  • 43 Bagavandoss P, Wilks JW. Specific inhibition of endothelial cell proliferation by thrombospondin. Biochem Biophys Res Commun 1990; 170: 867-872
    CrossrefPubMedSearch in Google Scholar
  • 44 Murphy-Ullrich JE, Höök M. Thrombospondin modulates focal adhesions in endothelial cells. J Cell Biol 1989; 109: 1309-1319
    CrossrefPubMedSearch in Google Scholar
  • 45 Lawler J, Weinstein R, Hynes RO. Cell attachment to thrombospondin: the role of ARG-GLY-ASP, calcium, and integrin receptors. J Cell Biol 1988; 107: 2351-2361
    CrossrefPubMedSearch in Google Scholar
  • 46 Canfield AE, Boot-Handford RP, Schor AM. Thrombospondin gene expression by endothelial cells in culture is modulated by cell proliferation, cell shape and the substratum. Biochem J 1990; 268: 225-230
    CrossrefPubMedSearch in Google Scholar
  • 47 Leung LLK, Li WX, McGregor JL, Albrecht G, Howard RJ. CD36 peptides enhance or inhibit CD36-thrombospondin binding. J Biol Chem 1992; 267: 18244-18250
    PubMedSearch in Google Scholar
  • 48 Yabkowitz R, Dixit VM. Human carcinoma cells bind thrombospondin through a Mr 80,000/105,000 receptor. Cancer Res 1991; 51: 3648-3656
    PubMedSearch in Google Scholar
  • 49 Asch AS, Barnwell J, Silverstein RL, Nachman RA. Isolation of the thrombospondin membrane receptor. J Clin Invest 1987; 79: 1054-1061
    CrossrefPubMedSearch in Google Scholar
  • 50 Karczewski J, Knudsen KA, Smith L, Murphy A, Rothman VL, Tuszynski GP. The interaction of thrombospondin with platelet glycoprotein GPIIb-IIIa. J Biol Chem 1989; 264: 21322-21326
    PubMedSearch in Google Scholar
  • 51 Guo NH, Krutzsch HC, Negre E, Vogel T, Blake DA, Roberts DD. Heparin-binding and sulfide-binding peptides from the type I repeats of human thrombospondin promote melanoma cell adhesion. Proc Natl Acad Sci USA 1992; 89: 3040-3044
    CrossrefPubMedSearch in Google Scholar
  • 52 Tolsma S, Volpert OV, Good DJ, Frazier WA, Polverini P, Bouck N. Peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activity. J Cell Biol 1993; 122: 497-511
    CrossrefPubMedSearch in Google Scholar
  • 53 Bornstein P. The thrombospondins: structure and regulation of expression. FASEB J 1992; 6: 3290-3299
    CrossrefPubMedSearch in Google Scholar
  • 54 Bornstein P, O’Rourke K, Wikstrom K, Wolf FW, Katz R, Li P, Dixit VM. A second expressed thrombospondin gene (Thbs2) exists in the mouse genome. J Biol Chem 1991; 266: 12821-12824
    PubMedSearch in Google Scholar
  • 55 LaBell TL, McGookey-Milewicz DJ, Disteche CM, Byers PH. Thrombospondin II: Partial cDNA sequence, chromosome location, and expression of a second member of the thrombospondin gene family in humans. Genomics 1992; 12: 421-429
    CrossrefPubMedSearch in Google Scholar
  • 56 Vos HL, Devarayalu S, de Vries Y, Bornstein P. Thrombospondin 3 (Thbs3), a new member of the thrombospondin gene family. J Biol Chem 1992; 267: 12192-12196
    PubMedSearch in Google Scholar
  • 57 Bornstein P, Devarayalu S, Edelhoff S, Disteche CM. Isolation and characterization of the mouse thrombospondin 3 (Thbs3) gene. Genomics 1993; 15: 607-613
    CrossrefPubMedSearch in Google Scholar
  • 58 Oldberg A, Antonsson P, Lindblom K, Heinegard D. COMP (cartilage oligomeric matrix protein) is structurally releated to the thrombospondins. J Biol Chem 1992; 267: 22346-22350
    PubMedSearch in Google Scholar
  • 59 Lawler J, Duquette M, Whittaker CA, Adams JC, McHenry K, DeSimone DW. Identification and characterization of thrombospondin-4, a new member of the thrombospondin gene family. J Cell Biol 1993; 120: 1059-1067
    CrossrefPubMedSearch in Google Scholar
  • 60 Reed MJ, Iruela-Arispe ML, O’Brien ER, Truong T, LaBell T, Bornstein P, Sage EH. Expression of thrombospondins by endothelial cells: injury is correlated with TSP-1. Am J Pathol 1995; 147: 1068-1080
    PubMedSearch in Google Scholar